Nucelis Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nucelis's estimated annual revenue is currently $1.6M per year.(i)
  • Nucelis's estimated revenue per employee is $155,000

Employee Data

  • Nucelis has 10 Employees.(i)
  • Nucelis grew their employee count by -33% last year.

Nucelis's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Senior Director, FermentationReveal Email/Phone
3
Research Scientist - Analytical ChemistryReveal Email/Phone
4
Dir, Strain DevelopmentReveal Email/Phone
5
Organic ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Nucelis?

The core goal of Nucelis is to consistently deliver high-value, performance-focused and sustainably-sourced ingredient solutions to the personal care, nutrition and flavor and fragrance markets. Through the use of natural repair mechanisms, The Nucelis RTDS system allows for predictable results without introducing foreign DNA. Mostly importantly, it has been certified as a non-GMO technology by the USDA. RTDS is a uniquely powerful technology with a wide range of applications. Examples of high value applications include, but are not limited to; the optimization of microorganisms to more efficiently produce specialty chemicals, the optimization of foods crops to increase their nutritional value, and curing genetic diseases in animals and humans. The Nucelis headquarters are located in San Diego, amidst a lively and active hub for the biotechnology industry.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M10N/AN/A
#2
$0.9M10N/AN/A
#3
$2.5M100%N/A
#4
$0.9M10400%N/A
#5
$0.6M10-62%N/A